Effect of bevacizumab against cystic components of brain tumors

BACKGROUND: Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented yet. MATERIALS AND METHODS: Between 2008 and 2018, 139 patie...

詳細記述

保存先:
書誌詳細
出版年:Cancer Med
主要な著者: Yamasaki, Fumiyuki, Kolakshyapati, Manish, Takano, Motoki, Yonezawa, Ushio, Nishibuchi, Ikuno, Imano, Nobuki, Taguchi, Akira, Onishi, Shumpei, Amatya, Vishwa Jeet, Takeshima, Yukio, Nagata, Yasushi, Kurisu, Kaoru, Sugiyama, Kazuhiko
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2019
主題:
Clinical Cancer Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825995/
https://ncbi.nlm.nih.gov/pubmed/31498567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2537
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料